Vice President
Scipher Medicine is a personalized medicine platform for patients with autoimmune diseases that interpret an individual’s own molecular data to ensure care is tailored to improve outcomes and guide therapeutic decision-making. Data is further analyzed to develop novel therapies for patients who do not respond to current standard of care. Scipher acquired CrossBridge in October 2022.